Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Img, 2009; 2:1126-1140, doi:10.1016/j.jcmg.2009.06.006
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Estep, J. D.
Right arrow Articles by Zoghbi, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Estep, J. D.
Right arrow Articles by Zoghbi, W. A.

State-of-the-Art Paper

The Role of Multimodality Cardiac Imaging in the Transplanted Heart

Jerry D. Estep, MD*, Dipan J. Shah, MD, Sherif F. Nagueh, MD, John J. Mahmarian, MD, Guillermo Torre-Amione, MD, PhD, William A. Zoghbi, MD

Department of Cardiology, Section of Heart Failure and Heart Transplantation, and Cardiovascular Imaging Institute, Methodist DeBakey Heart and Vascular Center, Houston, Texas

* Reprint requests and correspondence: Dr. Jerry D. Estep, Methodist DeBakey Heart and Vascular Center, Cardiology, Smith Tower, 6550 Fannin Street, Suite 1901, Houston, Texas 77030 (Email: jestep{at}tmhs.org).

Heart transplantation (HT) is an established life-saving treatment option for patients with end-stage heart failure. Despite many advances in the field, the development of acute cellular rejection (ACR) and cardiac allograft vasculopathy (CAV) represent significant causes of 1- and 5-year morbidity and mortality, respectively. The search for noninvasive techniques to assess cardiac allograft function and detect treatable ACR and CAV remains a priority objective for heart transplant professionals. In this review we will: 1) highlight the clinical significance of ACR and CAV in adult cardiac transplant recipients and 2) discuss how different noninvasive imaging modalities (echocardiography, cardiac computed tomography, myocardial perfusion imaging, and cardiac magnetic resonance) have been used in the evaluation of these clinical challenges after HT.

Key Words: heart transplant • acute cellular rejection • vasculopathy • cardiac imaging

Abbreviations and Acronyms
  ACR = acute cellular rejection
  CAV = cardiac allograft vasculopathy
  CMR = cardiac magnetic resonance
  DSE = dobutamine stress echocardiography
  EMB = endomyocardial biopsy
  HT = heart transplantation
  IVUS = intravascular ultrasound
  LV = left ventricular
  MACE = major adverse cardiac events
  MDCT = multidetector computed tomography
  SPECT-MPI = single-photon emission computed tomography-myocardial perfusion imaging
  TDI = tissue Doppler imaging




This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
M. F. Eleid, G. Caracciolo, E. J. Cho, R. L. Scott, D. E. Steidley, S. Wilansky, F. A. Arabia, B. K. Khandheria, and P. P. Sengupta
Natural History of Left Ventricular Mechanics in Transplanted Hearts: Relationships With Clinical Variables and Genetic Expression Profiles of Allograft Rejection
J. Am. Coll. Cardiol. Img., October 1, 2010; 3(10): 989 - 1000.
[Abstract] [Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link